(Q42694389)

English

Open-label randomized trial of the safety and efficacy of a single dose conivaptan to raise serum sodium in patients with traumatic brain injury

scientific article published on June 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Open-label randomized trial of the safety and efficacy of a single dose conivaptan to raise serum sodium in patients with traumatic brain injury (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

traumatic brain injury

0 references

author name string

Christopher Galton

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Steven Deem

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

N David Yanez

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Michael Souter

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Randall Chesnut

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Armagan Dagal

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Miriam Treggiari

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Neurocritical Care

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

354-360

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Management of intracranial hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Conivaptan for hyponatremia in the neurocritical care unit

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V(1) and V(2) receptors and nitric oxide

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Effects of vasopressin and oxytocin on canine cerebral circulation in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Vasopressin mediated vasodilation of cerebral arteries.

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Differing effects of vasopressin on regional cerebral blood flow of dogs following intracisternal vs. intra-arterial administration

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Effect of rapid correction of hyponatremia on the blood-brain barrier of rats

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9525-8

21 January 2018

Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21409494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for the direct effect of vasopressin on human and goat cerebral arteries

1 reference

https://pubmed.ncbi.nlm.nih.gov/21409494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasopressin in vascular regulation and water homeostasis in the brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21409494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21409494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12028-011-9525-8

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42694389&oldid=2205615403"